These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36653966)

  • 1. Acquired Hemophilia A: A Retrospective Multicenter Analysis of 42 Patients.
    Liu Y; Ruan X; Lei P; Shang B; Zhu Z; Chen S; Wang D; Wang R; Li X; Xue F
    Clin Appl Thromb Hemost; 2023; 29():10760296221151165. PubMed ID: 36653966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and prognostic factors of acquired haemophilia A in Korea.
    Hyun SY; Shin HJ; Yoon SS; Moon JH; Han JJ; Yang DH; Lee WS; Bang SM; Yhim HY; Kim SH; Oh D; Do YR; Park Y; Choi CW; Lee JH; Jang JE; Kim SJ; Hwang DY; Kim JS
    Haemophilia; 2021 Sep; 27(5):e609-e616. PubMed ID: 34156738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 study.
    Tiede A; Klamroth R; Scharf RE; Trappe RU; Holstein K; Huth-Kühne A; Gottstein S; Geisen U; Schenk J; Scholz U; Schilling K; Neumeister P; Miesbach W; Manner D; Greil R; von Auer C; Krause M; Leimkühler K; Kalus U; Blumtritt JM; Werwitzke S; Budde E; Koch A; Knöbl P
    Blood; 2015 Feb; 125(7):1091-7. PubMed ID: 25525118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired hemophilia A: a single-center study of 165 patients.
    Yu D; Xue F; Liu X; Chen Y; Fu R; Sun T; Dai X; Ju M; Dong H; Yang R; Liu W; Zhang L
    Res Pract Thromb Haemost; 2024 Jan; 8(1):102318. PubMed ID: 38433975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclophosphamide vs rituximab for eradicating inhibitors in acquired hemophilia A: A randomized trial in 108 patients.
    Lévesque H; Viallard JF; Houivet E; Bonnotte B; Voisin S; Le Cam-Duchez V; Maillot F; Lambert M; Liozon E; Hervier B; Fain O; Guillet B; Schmidt J; Luca LE; Ebbo M; Ferreira-Maldent N; Babuty A; Sailler L; Duffau P; Barbay V; Audia S; Benichou J; Graveleau J; Benhamou Y;
    Thromb Res; 2024 May; 237():79-87. PubMed ID: 38555718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitor eradication and bleeding management of acquired hemophilia A: a single center experience in China.
    Ye N; Liu Z; Xu G; Wang X; Wu F; Xu X; Wu W
    Hematology; 2019 Dec; 24(1):631-636. PubMed ID: 31514689
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of acquired hemophilia A, a balancing act: results from a 27-year Dutch cohort study.
    Schep SJ; van Dijk WEM; Beckers EAM; Meijer K; Coppens M; Eikenboom J; Leebeek FWG; van Vulpen LFD; Fischer KF; Schutgens REG;
    Am J Hematol; 2021 Jan; 96(1):51-59. PubMed ID: 32974947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overshoot of FVIII activity in patients with acquired hemophilia A who achieve complete remission.
    Ogawa Y; Yanagisawa K; Naito C; Uchiumi H; Ishizaki T; Shimizu H; Gohda F; Ieko M; Ichinose A; Handa H
    Int J Hematol; 2020 Apr; 111(4):544-549. PubMed ID: 31939075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).
    Collins P; Baudo F; Knoebl P; Lévesque H; Nemes L; Pellegrini F; Marco P; Tengborn L; Huth-Kühne A;
    Blood; 2012 Jul; 120(1):47-55. PubMed ID: 22517903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and outcomes of acquired hemophilia A: experience at a single center in Japan.
    Ogawa Y; Yanagisawa K; Uchiumi H; Ishizaki T; Mitsui T; Gouda F; Ieko M; Ichinose A; Nojima Y; Handa H
    Int J Hematol; 2017 Jul; 106(1):82-89. PubMed ID: 28299631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report.
    Drobiecki A; Pasiarski M; Hus I; Sokołowska B; Wątek M
    Blood Coagul Fibrinolysis; 2013 Dec; 24(8):874-80. PubMed ID: 24042266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twelve years of experience of acquired hemophilia A: trials and tribulations in South Australia.
    Tay L; Duncan E; Singhal D; Al-Qunfoidi R; Coghlan D; Jaksic W; Szabo F; McRae S; Lloyd J
    Semin Thromb Hemost; 2009 Nov; 35(8):769-77. PubMed ID: 20169513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced-intensity, risk factor-stratified immunosuppression for acquired hemophilia A: single-center observational study.
    Dobbelstein C; Moschovakis GL; Tiede A
    Ann Hematol; 2020 Sep; 99(9):2105-2112. PubMed ID: 32621181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes in the treatment of acquired hemophilia A: a 16-year single institution prospective cohort experience.
    Loloi J; Moroi MK; Songdej N; Al-Mondhiry HA
    Blood Coagul Fibrinolysis; 2020 Jan; 31(1):43-47. PubMed ID: 31789659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy of acquired hemophilia A.
    Tiede A
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):19-23. PubMed ID: 38066859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emicizumab for the treatment of acquired hemophilia A.
    Knoebl P; Thaler J; Jilma P; Quehenberger P; Gleixner K; Sperr WR
    Blood; 2021 Jan; 137(3):410-419. PubMed ID: 32766881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy.
    Field JJ; Fenske TS; Blinder MA
    Haemophilia; 2007 Jan; 13(1):46-50. PubMed ID: 17212724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous infusion of porcine factor VIII in the management of patients with factor VIII inhibitors.
    Rubinger M; Houston DS; Schwetz N; Woloschuk DM; Israels SJ; Johnston JB
    Am J Hematol; 1997 Oct; 56(2):112-8. PubMed ID: 9326353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tipping point: The critical role of therapeutic apheresis in a case of refractory acquired hemophilia.
    Losos M; Scrape S; Joshi S; Shmookler A; Chen J
    J Clin Apher; 2017 Dec; 32(6):564-566. PubMed ID: 27646211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired hemophilia a: retrospective analysis of 49 cases from a single Chinese hemophilia center.
    Yang Y; Xue F; Shi H; Wang H; Zhang L; Ji L; Yang R
    Clin Appl Thromb Hemost; 2015 Jan; 21(1):35-40. PubMed ID: 23677912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.